Bilateral orbital metastases from XXXX . A case of false pseudotumor.

@entity1 @entity1137 @entity0 @entity5 @entity406 @entity982 @entity6436 @entity3
OBJECTIVE: To inform clinicians of a metastatic orbital @entity5 that frequently masquerades as an orbital inflammatory syndrome and to stimulate thought regarding this @entity5 's fundamental pathobiology specific to its orbital involvement. DESIGN: Interventional case report and literature review. @entity1 : A 47-year-old @entity1 with an acquired, bilateral, diffusely infiltrative orbital process is described. INTERVENTION: The clinical and radiographic features of the @entity1 's orbital process are reported. The review of two prior fine-needle aspiration biopsy specimens failed to reveal a diagnosis. Histopathologic examination of an open surgical biopsy specimen included standard light microscopy of frozen and @entity406 -fixed, @entity982 -embedded tissue. RESULTS: Characteristics light microscopy findings suggested the diagnosis of metastatic @entity1137 of the breast. The @entity1 refused all therapeutic intervention and died 9 months after orbitotomy. CONCLUSION: The presentation of @entity0 metastatic to the orbit as a bilateral infiltrative process is far more common than appreciated previously. Its rate of bilateral orbital involvement is 20%, whereas this rate for other @entity5 is much lower. The authors report an additional case, review the clinical features of previous case reports and series, and discuss aspects of the metastatic process. @entity0 must be included in the differential diagnosis of infiltrative orbital processes encountered in adult female @entity1 . When " @entity6436 " is detected in an adult female @entity1 , a thorough medical history must be obtained and physical examination performed. If a possible primary @entity0 is indicated, one must be wary of metastatic disease, and a histologic orbital diagnosis is warranted. The frequency of orbital @entity3 and bilateral orbital involvement of this @entity5 reinforces the possibility for organ-specific metastases.
